We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
-15.38%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$605M
AUM Growth
-$43.1M
Cap. Flow
+$70M
Cap. Flow %
11.58%
Top 10 Hldgs %
48.94%
Holding
2,904
New
349
Increased
1,175
Reduced
755
Closed
206

Sector Composition

Rank Sector Weight
1 Financials 18.89%
2 Technology 11.62%
3 Healthcare 5.08%
4 Consumer Discretionary 3.93%
5 Energy 3.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLRE icon
1501
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.65B
$6K ﹤0.01%
139
CNR
1502
Core Natural Resources Inc
CNR
$4.45B
$6K ﹤0.01%
113
+7
+7% +$341
TXNM
1503
TXNM Energy Inc
TXNM
$5.94B
$6K ﹤0.01%
135
-10
-7% -$469
AAMI
1504
Acadian Asset Management
AAMI
$3.19B
$6K ﹤0.01%
308
+22
+8% +$451
WRK
1505
DELISTED
WestRock Company
WRK
$6K ﹤0.01%
142
+60
+73% +$2.82K
DCPH
1506
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$6K ﹤0.01%
469
+327
+230% +$3.61K
AEL
1507
DELISTED
American Equity Investment Life Holding Company
AEL
$6K ﹤0.01%
157
-17
-10% -$647
AXLA
1508
DELISTED
Axcella Health Inc. Common Stock
AXLA
$6K ﹤0.01%
120
RUTH
1509
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$6K ﹤0.01%
399
OPNT
1510
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$6K ﹤0.01%
500
SHI
1511
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
$6K ﹤0.01%
373
-2,334
-86% -$44.5K
TPTX
1512
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$6K ﹤0.01%
80
-215
-73% -$9.55K
ABR icon
1513
Arbor Realty Trust
ABR
$998M
$5K ﹤0.01%
390
ADNT icon
1514
Adient
ADNT
$1.5B
$5K ﹤0.01%
163
+140
+609% +$4.7K
ALLO icon
1515
Allogene Therapeutics
ALLO
$694M
$5K ﹤0.01%
436
+326
+296% +$2.89K
AMKR icon
1516
Amkor Technology
AMKR
$13.7B
$5K ﹤0.01%
275
+141
+105% +$2.68K
APLS
1517
DELISTED
Apellis Pharmaceuticals
APLS
$5K ﹤0.01%
101
+8
+9% +$365
ARI
1518
Apollo Commercial Real Estate
ARI
$885M
$5K ﹤0.01%
456
-208
-31% -$2.55K
ARKF icon
1519
ARK Blockchain & Fintech Innovation ETF
ARKF
$761M
$5K ﹤0.01%
313
AVNS
1520
DELISTED
Avanos Medical
AVNS
$5K ﹤0.01%
170
-10
-6% -$287
BEKE icon
1521
KE Holdings
BEKE
$18.8B
$5K ﹤0.01%
+272
New +$3.83K
CCK icon
1522
Crown Holdings
CCK
$13.1B
$5K ﹤0.01%
52
-61
-54% -$6.52K
CDNA icon
1523
CareDx
CDNA
$2.42B
$5K ﹤0.01%
221
DAN icon
1524
Dana Inc
DAN
$3.06B
$5K ﹤0.01%
332
+286
+622% +$4.43K
DHC
1525
Diversified Healthcare Trust
DHC
$2.14B
$5K ﹤0.01%
2,900
-100
-3% -$229

Similar funds

Lindbrook Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Lindbrook Capital held 2,904 positions worth $605M, down 6.6% from $648M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Lindbrook Capital deployed $70M of net new capital in Q2 2022, opening 349 new positions and adding to 1,175 existing holdings. Its largest new stake was BlackRock MuniHoldings California Quality Fund: 50,522 shares worth $605K.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Digital Turbine, an estimated $3.57M trimmed.

  • Lindbrook Capital's largest Q2 2022 buy was BlackRock MuniHoldings California Quality Fund: 50,522 shares worth $605K.
  • Lindbrook Capital added most to Golub Capital BDC in Q2 2022, an estimated $26.1M increase.
  • Lindbrook Capital's biggest Q2 2022 reduction was Digital Turbine, cutting an estimated $3.57M.
  • Lindbrook Capital fully exited Berkshire Hathaway Class A in Q2 2022, selling an estimated $1.06M.
  • Lindbrook Capital's ten largest holdings make up 49% of its $605M portfolio in Q2 2022.
  • Lindbrook Capital opened 349 new positions and closed 206 in Q2 2022.
  • Lindbrook Capital's portfolio value fell 6.6% quarter-over-quarter to $605M.

Based on Lindbrook Capital's 13F filing for Q2 2022, filed 1 Aug 2022.